DS Research

Dermatology Specialists Research

  • Home
  • Who We Are
    • About
    • Meet Nina M. Scott
    • Meet Our Doctors
    • Meet Our Staff
  • Facilities
    • Kentucky Facility
    • Indiana Facility
    • Travel Accommodations
  • Research Studies
    • Enrolling Studies
  • Sponsor/CRO
  • News
  • Contact

Understanding Mental Health as a Psoriasis Comorbidity

November 9, 2022 by admin

As common as Psoriasis is, the comorbidities associated with Psoriasis are often overlooked by patients and sometimes their physicians. As a part of their Psoriasis comorbidities series, Delaney Drew, and Kristi Hawley, DO have been publishing monthly articles to better identify, understand, and associate these issues.

In part 2 published in October, mental health comes into focus. A comorbidity that can be both difficult to diagnose and associate with Psoriasis that is far too common with those suffering from the disease. With shared mechanisms in pathogeneses of Psoriasis and depression and an association with an increased risk of anxiety, low self-esteem, stress, and more, a deeper understanding of this comorbidity and how to screen for mental health risks is necessary.

In this article a few key takeaways are discussed including:

  • Psoriasis is a multifactorial systemic disease that affects 1% to 3% of the global population.
  • Psoriasis has been associated with several mental health adverse effects, including increased risk of anxiety, depression, low self-esteem, alexithymia (difficulty identifying or expressing emotions), stress, self-harm, and suicidality.
  • Patients with psoriasis have an elevated risk of suicidal ideation and behavior.
  • Shared mechanisms in the pathogeneses of psoriasis and depression include an increase in circulating inflammatory cytokines TNF-  , IL-1  , IL-2 , INF –   , IL – 6 , IL – 17  IL – 13  and brain-derived neuropathic factor which plays a role in neuropathic and mental health disorders.
  • Managing all comorbidities associated with psoriasis can constitute a considerable task for the clinician. The use of screening tools may help discover patients in need of referral to psychotherapy and other specialties or further investigation.

To explore this connection further, please read the full article on The Dermatologist linked below:

Read The Full Article>

Uncategorized

Contact Us

DS Research – Kentucky Location
3810 Springhurst Blvd.
Suite 130
Louisville, KY 40241
O: 502.585.9059
F: 502.585.9708

DS Research – Indiana Location
1005 E. Lewis & Clark Pkwy
Clarksville, IN 47129
O: 502.373.2849
F: 502.373.2872

Interested About Coming To Us? Our doctors are ready to see you now.

  • This field is for validation purposes and should be left unchanged.

dsrtrials

Are you struggling with #eczema? Call us today to Are you struggling with #eczema? Call us today to find out how we can help!
New Enrolling Studies⭐️⭐️⭐️ Give us a New Enrolling Studies⭐️⭐️⭐️ Give us a call today for more information on how we can help you achieve clear skin💚
.
.
.
.
.
.
#dsresearch #dermatology #kentucky #indiana #skin #eczema #psoriasis #alopecia #allergies #research #clinicaltrials
We had a sweet little Valentine visit us today❤️🪴🌹
Tonight we said farewell to one of our amazing coo Tonight we said farewell to one of our amazing coordinators as she starts a heavy semester as a nurse practitioner student. We are so happy and excited for her and very glad we were all able to get together one last time. Thank you Megan for all you have done! We will miss you.
Load More... Follow on Instagram

Copyright © 2023 DS Research :: Dermatology Specialists Research

  • Facebook
  • Instagram
  • LinkedIn
  • Pinterest
  • Twitter